Correction to: Inhibition of the AURKA/YAP1 axis is a promising therapeutic option for overcoming cetuximab resistance in colorectal cancer stem cells (British Journal of Cancer, (2024), 130, 8, (1402-1413), 10.1038/s41416-024-02649-z) - Rio-Vilariño, A.; Cenigaonandia-Campillo, A.; García-Bautista, A.; Mateos-Gómez, P.A.; Schlaepfer, M.I.; del Puerto-Nevado, L.; Aguilera, O.; García-García, L.; Galeano, C.; de Miguel, I.; Serrano-López, J.; Baños, N.; et al. (British Journal of Cancer, 2024)